Premas Biotech Announces Successful Completion Of Its Vaccine Prototype Of Triple-Antigen candidate against Covid-19
![](https://healthwire.co/wp-content/uploads/2020/05/Premas-Biotech.jpeg)
Gurgaon-based Premas Biotech has successfully completed its vaccine prototype by obtaining transmission electron microscopic (TEM) images of the recombinant virus-like particle (VLP) assembled by using an exclusive D-Crypt™ technology, which…
Share